|
What is Mitraclip?
MitraClip is FDA approved for the treatment of mitral regurgitation. The device is a small clip that is attached to your mitral valve leaflet using special catheters and imaging technqiues. It treats mitral regurgitation by allowing your mitral valve to close more completely, thus restoring normal blood flow through your heart and to your body. This procedure does not require opening the chest or stopping the heart. Instead, through a vein in the leg, a thin tube (called a catheter) is guided to the mitral valve Is Mitraclip Experimental?
No. Mitraclip is NOT experimental. It is FDA approved for certain types of patients with mitral regurgitation. Nearly 100,000 patients have been treated with the MitraClip device globally. |
Mitraclip is FDA-approved for the treatment of mitral regurgitation. Worldwide more than 100,000 Mitraclip procedures have been performed Dr. Russo is one of the most experienced catheter-based surgeons in the US, and is one of the highest volume mitraclip operators in the Northeast. |
|
What are the possible benefits of the MitraClip procedure?
As reported in the New England Journal of Medicine and the New York Times, appropriately selected patients who underwent the MitraClip procedure experienced significant reduction in mitral regurgitation, improved survival, improved quality of life, and less time in the hospital compared to optimal medical therapy. |
|
|
What information is needed before I can
undergo the procedure? Evaluation includes non-invasive echo for assessment of heart function and the valve anatomy. Typically, patients receive this testing in a single day. |
|
What should I expect when undergoing the Mitraclip procedure?
The Mitraclip procedure typically takes 1-2 hours; most patients return home the day following the procedure Most often there is no significant recovery period. Patients typically spent only single night in the hospital. |
Mitraclip
|
